Drug Approval | June 23, 2022
Menarini Group and Radius Health submit new drug application to the USFDA for Elacestrant
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
Bringing next-gen cannabinoid therapeutics to cancer patients
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Both manufacturing facilities are based out of Benguluru, India
Wedgewood Pharmacy operates compounding pharmacies that offers sterile and non-sterile compounded medications for animal patients in 50 states.
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Subscribe To Our Newsletter & Stay Updated
